Nephrotic Syndrome as a Complication of Immune Tolerance in Hemophilia B

作者: B.M. Ewenstein , C. Takemoto , I. Warrier , J. Lusher , P. Saidi

DOI: 10.1182/BLOOD.V89.3.1115

关键词:

摘要: To the Editor: Inhibitors to factor IX (fIX) develop in approximately 1.5% 3% of persons with severe hemophilia B and are commonly associated complete absence fIX antigen due large gene deletions or nonsense mutations.[1][1] The occurrence high-titer inhibitors severely

参考文章(7)
J G Gilles, B Desqueper, H Lenk, J Vermylen, J M Saint-Remy, Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. Journal of Clinical Investigation. ,vol. 97, pp. 1382- 1388 ,(1996) , 10.1172/JCI118558
Doreen B. Brettler, 8 Inhibitors in congenital haemophilia Baillière's clinical haematology. ,vol. 9, pp. 319- 329 ,(1996) , 10.1016/S0950-3536(96)80066-7
E. Berntorp, I. M. Nilsson, Immune Tolerance and the Immune Modulation Protocol Vox Sanguinis. ,vol. 70, pp. 36- 41 ,(1996) , 10.1111/J.1423-0410.1996.TB01347.X
I. M. Nilsson, E. Berntorp, O. Zettervall, Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 9169- 9173 ,(1986) , 10.1073/PNAS.83.23.9169
J. Stewart Cameron, Membranous nephropathy in childhood and its treatment. Pediatric Nephrology. ,vol. 4, pp. 193- 198 ,(1990) , 10.1007/BF00858840
G Mariani, A Ghirardini, R Bellocco, Immune Tolerance in Hemophilia-Principal Results from the International Registry Thrombosis and Haemostasis. ,vol. 72, pp. 155- 158 ,(1994) , 10.1055/S-0038-1648828